Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-14-266334
Filing Date
2014-07-11
Accepted
2014-07-11 13:55:22
Documents
7
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d722469d10qa.htm 10-Q/A 27598
  Complete submission text file 0001193125-14-266334.txt   4662053

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT scyx-20140331.xml EX-101.INS 627855
3 XBRL TAXONOMY EXTENSION SCHEMA scyx-20140331.xsd EX-101.SCH 64103
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20140331_cal.xml EX-101.CAL 61129
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20140331_def.xml EX-101.DEF 198717
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20140331_lab.xml EX-101.LAB 406487
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20140331_pre.xml EX-101.PRE 316692
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36365 | Film No.: 14971337
SIC: 2834 Pharmaceutical Preparations